The BD2 Integrated Network Released Data From 615 Participants Across Six Sites, Creating the Most Comprehensive Psychiatric Research Resource Ever Assembled

The largest bipolar disorder dataset in the history of psychiatry is now available to researchers worldwide. This could mark the beginning of a new era in how the condition is diagnosed and treated.

The Breakthrough Discoveries for Thriving with Bipolar Disorder (BD2) Integrated Network announced on March 30 the public release of its first curated, de-identified dataset. Clinical assessments. Brain imaging. Blood-based biomarkers. Continuous wearable sensor data. All from 615 participants across six research sites in the United States.

No psychiatric dataset has ever combined this many data types at this scale. Not for a single condition.

The initiative, funded by the National Institute of Mental Health, was designed from the ground up to close persistent gaps in bipolar disorder research. Here’s the honest version: depression and schizophrenia have large-scale longitudinal studies. Bipolar disorder has lagged. Especially when it comes to integrating biological, behavioral, and digital data into a single resource.

The BD2 dataset changes that. Clinical component: both clinician-administered and self-reported measures covering mood episodes, cognitive function, social determinants of health. Neuroimaging: high-resolution MRI scans mapping brain structure and functional connectivity. Blood samples: standardized bioassays examining inflammation, metabolic function, stress markers. And the wearable data, collected from Fitbit devices, captures daily sleep, activity patterns, circadian rhythms, movement cycles. Over time.

That combination is what makes this release different from anything that came before. Rather than studying bipolar disorder through one lens, scientists can look for patterns across biology, behavior, and daily life at the same time.

The potential implications are significant. What strikes me about this dataset is that it treats bipolar as something multidimensional. With enough data, researchers might identify subtypes that respond differently to treatment. Predict who is at risk for relapse. Develop early-warning tools based on wearables alone. This is what the field calls precision psychiatry: care tailored to the individual, not just the diagnosis.

The BD2 network plans additional releases as recruitment continues and they add new modalities. The dataset is available to qualified researchers, all identifiable information removed.

For the estimated 4.4 percent of adults worldwide who will live with bipolar disorder, the promise is straightforward. Better data should eventually mean better care.

A note from Jayne Millerton: Most of us living with bipolar disorder have been treated with the same handful of drugs and the same general approach for decades. The idea that researchers now have a single place to study brain scans, bloodwork, daily activity, and clinical history all at once feels like the kind of shift that could actually move the needle. I hope it does.

See recent or related posts:
• Largest Genetic Study Ever Links 14 Psychiatric Conditions, Including Bipolar
• Scientists Just Mapped the Genetic Blueprint of Mania
• Your Gut May Be Influencing Your Bipolar Mood Swings
• New Wearable Sensor Could Help Patients with Bipolar Disorder Track Medication
• Cognitive Impairments in Bipolar Disorder: Research Shows More Than Mood Swings